Stock Market Rockets and Millstones in the Third Week of April
Advanced stock trading software has made the stock market more accessible to the public. April’s third week had one really spectacular winner, among others, and its share of losers too.
Most Prominent Gainers
The stock market really treated Mustang Bio ($MBIO) well, and it was one of the biggest gainers, soaring 112.03% to register a Strong Buy on TradingView.com. As the Motley Fool reported, the gene therapy stock really was “on fire” on Friday, gaining 358% in the early-morning trading. The news of its MB-107 experimental gene therapy curing eight boys suffering from the deadly bubble boy disease or XSCID (x-linked severe combined immunodeficiency) did a world of good for Mustang Bio, something even the company would not have expected. The next stock that soared was Checkpoint Therapeutics Inc. ($CKPT). It rose 20.73%, securing a Buy rating on TradingView. Amyris Inc. ($AMRS) rose 20.10% and is a Buy. In the S&P 500, United Rentals Inc. ($URI) rose 8.14% for a Strong Buy.
StoneCo Ltd ($STNC), the Brazilian fintech company, lost a whopping 23.69%, earning a Sell rating on TradingView. Motley Fool suspects the reason for the dip to be the move by rival ItauUnibanco Holding SA ($ITUB) to extend credit card payments for merchants of small and medium-sized businesses. Steel wire reinforcing manufacturer Insteel Industries ($IIIN) lost 21.41%. Chinese electric scooter manufacturer Niu Technologies ($NIU) lost 19.06% to earn a Sell rating. In the S&P 500, Genuine Parts Co ($GPC) lost 6.33% and earned a Sell rating on TradingView.
The content provided here is solely for informational and educational purposes and does not constitute an offer to sell or a solicitation to buy any security or instrument which may be referenced upon the site, or an offer to provide advisory or other services by TradeZero in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Investors are advised not to rely on the information contained in this writing to make an informed investment or financial decision. TradeZero explicitly disclaims all liability for any action taken based on any information contained in this writing.